-
ABUS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arbutus Biopharma (ABUS)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 31.85 mm | 31.85 mm | 31.85 mm | 31.85 mm | 31.85 mm | 31.85 mm |
Cash burn (monthly) | 3.75 mm | (no burn) | 7.15 mm | 6.93 mm | (no burn) | 4.56 mm |
Cash used (since last report) | 10.47 mm | n/a | 19.94 mm | 19.32 mm | n/a | 12.73 mm |
Cash remaining | 21.38 mm | n/a | 11.91 mm | 12.52 mm | n/a | 19.12 mm |
Runway (months of cash) | 5.7 | n/a | 1.7 | 1.8 | n/a | 4.2 |
13F holders | Current |
---|---|
Total holders | 70 |
Opened positions | 20 |
Closed positions | 56 |
Increased positions | 22 |
Reduced positions | 16 |
13F shares | Current |
---|---|
Total value | 187.56 bn |
Total shares | 99.74 mm |
Total puts | 91.60 k |
Total calls | 3.16 mm |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
ROIV Roivant Sciences | 38.85 mm | $160.83 mm |
MS Morgan Stanley | 20.96 mm | $64.77 bn |
Whitefort Capital Management | 12.87 mm | $39.76 bn |
Kairos Capital Management | 8.57 mm | $26.49 bn |
Adage Capital Partners GP, L.L.C. | 3.00 mm | $9.27 bn |
FourWorld Capital Management | 2.97 mm | $9.19 bn |
STT State Street | 2.93 mm | $9.07 bn |
BlackBarn Capital Partners | 2.07 mm | $6.40 bn |
Hudson Bay Capital Management | 1.69 mm | $5.21 bn |
Woodline Partners | 926.53 k | $2.86 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Aug 24 | Manchester Keith S | Common Shares | Sell | Dispose S | No | No | 3.6895 | 8,846 | 32.64 k | 46,069 |
14 Aug 24 | Manchester Keith S | Common Shares | Option exercise | Acquire M | No | No | 0.56 | 54,915 | 30.75 k | 54,915 |
14 Aug 24 | Manchester Keith S | Stock Option Common Shares | Option exercise | Dispose M | No | No | 0.56 | 54,915 | 30.75 k | 0 |
23 May 24 | Meyers James R | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
23 May 24 | Burgess Daniel D | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
23 May 24 | Manchester Keith S | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |
23 May 24 | Torti Frank | Stock Option Common Shares | Grant | Acquire A | No | No | 3.28 | 67,000 | 219.76 k | 67,000 |